Understanding the biology of an ADCK4-NUMBL fusion in lung adenocarcinoma aggressiveness

$147,264U54FY2025CANIH

H. Lee Moffitt Cancer Ctr & Res Inst, Tampa FL

Investigators

Linked publications & trials

Paper 39682213 Paper 39543072 Paper 39162297 Paper 38886738 Paper 38076882 Paper 37708699 Paper 37702848 Paper 37568698 Paper 37370195 Paper 37174739 Paper 37122033 Paper 37121178 Paper 37028174 Paper 36901468 Paper 36444126 Paper 36334169 Paper 36205471 Paper 36098498 Paper 35941731 Paper 35845857 Paper 35804887 Paper 35778318 Paper 35500227 Paper 35499269 Paper 35491768 Paper 35379609 Paper 35301804 Paper 34968222 Paper 34365840 Paper 34298708 Paper 34253763 Paper 34205709 Paper 34138895 Paper 33907253 Paper 33683687 Paper 33683686 Paper 33658259 Paper 33601912 Paper 33450964 Paper 33410819 Paper 33310066 Paper 33154993 Paper 33028079 Paper 32962103 Paper 32961801 Paper 32936981 Paper 32914912 Paper 32901135 Paper 32587352 Paper 32350296 Paper 32213975 Paper 31780696 Paper 31771680 Paper 31575294 Paper 31456910 Paper 31318876 Paper 31314158 Paper 30894373 Paper 30682163 Paper 30505391 Paper 30487138 Paper 30482165 Paper 30452490 Paper 30400234 Paper 30381801 Paper 30324180 Paper 30206215 Paper 30040709 Paper 29976631 Paper 29888762 Paper 29844388 Paper 29674220 Paper 29661830 Paper 29629944 Paper 29468550 Paper 29468545 Paper 29468543 Paper 29408993 Paper 29356578 Paper 29318955 Paper 29238632 Paper 29220064 Paper 29169975 Paper 29100415 Paper 28911955 Paper 28858227 Paper 28855975 Paper 28704967 Paper 28441375 Paper 28378199 Paper 28195434 Paper 28127413 Paper 28090172 Paper 28008224 Paper 27957667 Paper 27842333 Paper 27842325 Paper 27842323 Paper 27756884 Paper 27722911

Abstract

Lung malignancies are the leading cause of cancer death. We have identified an ADCK4-NUMBL cis-SAGe fusion transcript by screening a cohort of lung adenocarcinoma patients known to lack typical oncogenic drivers. Cis-splicing between adjacent genes (cis-SAGe) is an understudied biological mechanism associated with an increase in genomic complexity. We find that the ADCK4-NUMBL fusion transcript is detectable in normal immortalized lung epithelial cells and at various levels in seven lung cancer cell lines evaluated. Likewise, measurement of the ADCK4-NUMBL Exon 14-Exon 2 transcripts in RNA derived from tumors from patients with lung adenocarcinoma revealed significant variation. A cohort of 193 lung adenocarcinoma patients was divided into high and low ADCK4-NUMBL expression groups, and overall survival comparisons were made. Kaplan- Meier analysis revealed that patients with high RNA expression (above the median) of ADCK4-NUMBL have diminished overall survival (Log-rank p <0.001) compared to patients with low expression. ADCK4-NUMBL levels were elevated in self-identified Black patients (p = 0.01), in smokers (p = 0.03), and in patients with KRAS mutations (p <0.04). No differences in ADCK4-NUMBL expression were observed when comparing patients by sex, age, stage, or body mass index. NUMBL immunoprecipitation, gel electrophoresis, and mass spectrometry analysis support the conclusion that the endogenous ADCK4-NUMBL transcript produces a protein product. Enforced expression of the ADCK4-NUMBL Exon 14-Exon 2 protein in A549 cells results in accelerated cell proliferation. These preliminary findings lead us to hypothesize that the ADCK4-NUMBL transcript produces an oncogenic protein that contributes significantly to lung cancer aggressiveness in a subset of lung cancer patients. In this pilot study, we propose the following exploratory aims to probe deeper into this general hypothesis and generate a strong premise for a future R01 application.

View original record on NIH RePORTER →